Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Javier, Perez Irizarry"'
Autor:
Syim Salahuddin, Oded Cohen, Margaret Wu, Javier Perez Irizarry, Teresita Vega, Geliang Gan, Yanhong Deng, Natalia Isaeva, Manju Prasad, Kurt A Schalper, Saral Mehra, Wendell G Yarbrough, Brinda Emu
Publikováno v:
Clinical Infectious Diseases. 76:1449-1458
Background Head and neck squamous cell cancer (HNSCC) occurs at higher rates among persons with HIV (PWH). This study compares the impact of sociodemographic and clinicopathologic characteristics on outcomes among PWH-HNSCC compared with HNSCC patien
Autor:
Syim, Salahuddin, Oded, Cohen, Margaret, Wu, Javier, Perez Irizarry, Teresita, Vega, Geliang, Gan, Yanhong, Deng, Natalia, Isaeva, Manju, Prasad, Kurt A, Schalper, Saral, Mehra, Wendell G, Yarbrough, Brinda, Emu
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Head and neck squamous cell cancer (HNC) occurs at higher rates among people with HIV (PWH). This study compares the impact of sociodemographic and clinicopathologic characteristics on outcomes among PWH-HNSCC compared to Uninfected- HNSCC patients.P
Autor:
Syim Salahuddin, Kurt A. Schalper, Wendell G. Yarbrough, Margaret Wu, Teresita Vega, Natalia Isaeva, Brinda Emu, Javier Perez Irizarry
Publikováno v:
Clinical Research (Excluding Clinical Trials).
Introduction: Incidence of non-AIDS-defining cancers, including head and neck cancer (HNC), is rising among people living with HIV (PLWH). This study compares outcomes of HIV+ and Uninfected HNC patients at a single institution. Methods: Yale Tumor R
Autor:
Syim Salahuddin, Oded Cohen, Margaret Wu, Javier Perez Irizarry, Teresita Vega, Geliang Gan, Yanhong Deng, Natalia Isaeva, Kurt A. Schalper, Saral Mehra, Wendell Gray Yarbrough, Brinda Emu
Publikováno v:
Journal of Clinical Oncology. 40:e18080-e18080
e18080 Background: Incidence of non-AIDS-defining cancers, including head and neck cancer (HNC), is rising among people with HIV (PWH) in the combination antiretroviral therapy (cART) era. The following study compares demographics, clinical outcomes,
Autor:
Debu Tripathy, Javier Perez Irizarry, Carlos H. Barcenas, Teresita Vega, Lajos Pusztai, Yao Wong, Akshara Singareeka Raghavendra, Vicente Valero, Mariana Chavez-MacGregor, Nina R. Horowitz, Rashmi Krishna Murthy, Christos Hatzis
Publikováno v:
The Oncologist. 24:313-318
Background An increasing proportion of human epidermal growth receptor 2 (HER2) positive (HER2+) metastatic breast cancer (MBC) is diagnosed as de novo stage IV disease. We hypothesize that a subset of these patients who achieve no evidence of diseas
Autor:
Gabriella Grisotti, Sajid A. Khan, Ronald R. Salem, Javier Perez-Irizarry, Fangfang Liu, Kimberly L. Johung, Rebecca Zhu, Daniel J. Boffa, Yawei Zhang, Charles Cha
Publikováno v:
Journal of Gastrointestinal Oncology. 9:517-526
Background: Adjuvant therapy for gastric adenocarcinoma has shown a survival advantage, though it may be underutilized. The purpose of this study is to examine how infrequently adjuvant therapy is administered with curative intent gastrectomy for nod
Autor:
Fangfang Liu, Javier Perez-Irizarry, Kimberly L. Johung, Sajid A. Khan, Daniel J. Boffa, Gabriella Grisotti, Rebecca Zhu, Yawei Zhang, Charles Cha, Caroline H. Johnson, Dale Han
Publikováno v:
Journal of Gastrointestinal Oncology. 9:231-240
Background Colon and rectal gastrointestinal stromal tumors (GISTs) are rare and poorly characterized. Because the majority of treatment guidelines for GISTs are extrapolated from tumors of gastric and small bowel origin, our aim was to better charac
Autor:
Javier Perez-Irizarry, Pei Hui, Babak Litkouhi, Alessandro D. Santin, Masoud Azodi, Jonathan Black, Rachel Passarelli, Amanda Rostkowski, Karen Levy, Uma Deshmukh, Peter E. Schwartz, Thomas J. Rutherford, Dan-Arin Silasi, Elena Ratner
Publikováno v:
Reproductive sciences (Thousand Oaks, Calif.). 26(5)
To compare aromatase inhibitors (AIs) with progestins as adjuvant hormonal therapy(AHT) for low-grade endometrial stromal sarcomas (LGESSs).We reviewed cases with LGESS at our institution from 1984 to 2017. Disease recurrence and recurrence-free surv
Autor:
Kerin B. Adelson, Peter Longley, Javier Perez-Irizarry, Teresita Vega, Salimah Velji, Susan K. Lipka, Junchao Ma, Rogerio Lilenbaum, Joan M. Rimar, Donald K. K. Lee, Edieal J. Pinker
Publikováno v:
Journal of oncology practice. 14(3)
Purpose: End-of-life care for patients with advanced cancer is aggressive and costly. Oncologists inconsistently estimate life expectancy and address goals of care. Currently available prognostication tools are based on subjective clinical assessment
Autor:
Teresita Vega, Vicente Valero, Debu Tripathy, Akshara Singareeka Raghavendra, Rashmi Krishna Murthy, Yao Wong, Javier Perez Irizarry, Mariana Chavez-Mac Gregor, Carlos H. Barcenas, Lajos Pusztai, Christos Hatzis
Publikováno v:
Journal of Clinical Oncology. 35:1021-1021
1021 Background: An increasing number of metastatic HER2 positive cancers represent de novo stage IV disease as fewer early stage patients relapse. We hypothesize that a subset of these has long progression free survival (PFS) after initial combined